Table 5 Clinicopathologic and molecular features of pancreatic tubular adenocarcinoma.
ID | Sex | Age | Survival (months) | Site/Size (cm) | Grading | pT | pN | cM | KRAS | TP53 | CDKN2A/p16 | SMAD4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
# 44 | F | 82.6 | 19.3 | head/4.2 | G1 | T3 | N1 | M0 | mut (p.G12V) | intact | altered | intact |
# 62 | M | 74.9 | >68.6, still alive | head/3.8 | G1 | T3 | N0 | M0 | wt | intact | intact | intact |
# 190 | M | 50.0 | >55.3, still alive | head/3.5 | G1 | T3 | N1 | M0 | mut (p.G12C low-level mutation, 6%) | intact | intact | intact |
